earnings
confidence high
sentiment positive
materiality 0.85
PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)
PROCEPT BioRobotics Corp
2024-FY EPS reported
-$1.75
revenue$224,498,000
- Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).
- FY2024 rev $224.5M (+65%); net loss narrowed to $91.4M from $105.9M; adj EBITDA loss $61.1M vs $86.5M.
- FY2025 guidance: rev ~$320M (+42%); gross margin ~64.5%; adj EBITDA loss ~$35M.
- Cash $333.7M, debt $52.0M; US install base 505 AquaBeam/HYDROS systems.
- Q4 saline shortage delayed ~10-20% of Aquablation procedures, impacting handpiece order patterns.